SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 28, 14:06
2997.15
8.75 (0.29%)
VOLUME 71,032
LIVE
NSE
Jul 28, 14:06
2996.40
16.2 (0.54%)
VOLUME 723,645
News on Dr Reddys Laboratories
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
NMDC positional buy, stay with Dr Reddy's Labs: Sukhani 

10.58 am | 28 Jul 2016 |  Source: CNBC-TV18

According to Sudarshan Sukhani of s2analytics.com, NMDC positional buy and feels that one can stay with Dr Reddy's Labs. ...

Buy Divi's Labs & Godrej Industries: Manoj Murlidharan 

10.23 am | 28 Jul 2016 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Manoj Murlidharan of Religare Securities shared his readings and outlook on Futures and Options (F&O) side of the market...

Buy Sun Pharma; Ajanta Pharma better than Lupin: Sukhani 

9.38 am | 28 Jul 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharma and feels that Ajanta Pharma better than Lupin....

New launches in H2FY17 will boost growth: Dr Reddy's 

3.44 pm | 27 Jul 2016 |  Source: CNBC-TV18

The fall in revenue and profits in the first quarter was due to lack of launches in the US, says Saumen Chakraborty, CFO of Dr Reddy’s. The company ...

DRL may go for product filings in LatAM, APAC, North Africa

2.34 pm | 27 Jul 2016 |  Source: PTI

The letter has resulted in a delay of some of important product launches this year and also necessitated a significant cost towards the remediation ef...

Top Buzzers: Dr Reddy's Lab, Manali Petrochemicals, ADF Foods

10.56 am | 27 Jul 2016 |  Source: Moneycontrol.com

Shares of Manali Petrochemicals added nearly 9 percent intraday on approval received from Tamil Nadu Pollution Control Board (TNPCB)....

Valuations stretched but mkt will stay afloat on liquidity: CLSA 

10.00 am | 27 Jul 2016 |  Source: CNBC-TV18

CLSA India Strategist Mahesh Nandurkar says that given the easy liquidity situation, the market screen is likely to stay green....

Competition bothering DRL, will shift to other stocks: Tulsian 

9.42 am | 27 Jul 2016 |  Source: CNBC-TV18

In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his reading and outlook on the market as well as on various stocks and sectors....

Strongly bullish on Dr Reddy's Labs, target Rs 3405: Rajat Bose 

9.36 am | 27 Jul 2016 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com is Dr Reddy's Laboratories strongly bullish on Dr Reddy's Laboratories with a target of Rs 3405....

Dr Reddy's tanks 10% on slew of downgrades & target cut post Q1 

9.28 am | 27 Jul 2016 |  Source: Moneycontrol.com

Decline in volume growth, particularly in the US market, loss of business in Venezuela, price erosion and delayed launches due to warning letters impa...

Dr Reddy's Labs will head to Rs 4500, says Sudarshan Sukhani 

9.08 am | 27 Jul 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that Dr Reddy's Labs will eventually go to Rs 4,500....

Stocks that must be on your radar 

8.54 am | 27 Jul 2016 |  Source: CNBC-TV18

Some of the stocks that should be on your radar are: Jindal Steel & Power, Equitas Holdings, Dr Reddys Laboratories, Ambuja Cements, Zee Entertainment...

Quick tips: How to trade 4 largecaps stocks post Q1 results

8.36 am | 27 Jul 2016 |  Source: Moneycontrol.com

Credit Suisse downgrades DRL to underperform from neutral as sharp erosion in the US business leads to high EPS cut. It has also slashed FY17/18 EPS b...

Indian assets doing well; hopeful of few launches in US: DRL 

9.37 pm | 26 Jul 2016 |  Source: CNBC-TV18

For the first quarter ended June, Dr Reddy’s Laboratories missed estimates on all counts. Revenue declined 14 percent to Rs 3,222.5 crore in the qua...

Tulsian's take on paper, PSU bank stocks & outlook on Nifty 

5.13 pm | 26 Jul 2016 |  Source: CNBC-TV18

In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his outlook on Nifty. "We need to see rollover. But if I just take a broad call for t...

No disturbing trend in Dr Reddy's numbers except topline: Expert 

4.50 pm | 26 Jul 2016 |  Source: CNBC-TV18

Shetty says that she has her doubts on a possible revival of revenues saying that the eight drugs bought from Teva for the US market, will take till 2...

Six in Sixty: Stocks you should keep on your radar 

3.11 pm | 26 Jul 2016 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on....

Dr Reddy's Q1 disappoints; profit cracks 76%, US sales fall 16% 

2.52 pm | 26 Jul 2016 |  Source: Moneycontrol.com

"Topline and bottomline impacted by a decline in volume growth, particularly in the US market and loss of business in Venezuela," the pharma major sai...

Buy Bajaj Finance, JSW Steel; short Dr Reddy's Labs: Ashish Kyal 

1.18 pm | 26 Jul 2016 |  Source: CNBC-TV18

Ashish Kyal of wavesstrategy.com is of the view that one can buy Bajaj Finance and JSW Steel and short Dr Reddy's Labs....

Here are Edelweiss' 3 concerns that could hit Dr Reddy's 

1.02 pm | 26 Jul 2016 |  Source: CNBC-TV18

An increase in competition in the US business is going to lead to pricing pressure for Dr Reddy's Laboratories. This can lead to a fall in margins for...

1 2 3 4 5 6 7 8 9 10
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.